Dark Forest Capital Management LP Deciphera Pharmaceuticals, Inc. Transaction History

Dark Forest Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$12.46 - $15.48 $119,030 - $147,880	9,553 Added 18.86%	60,216 $765,000
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $660,972 - $794,361	49,772 Added 5586.08%	50,663 $713,000
Q1 2023 May 12, 2023	BUY	$14.26 - $22.1 $12,705 - $19,691	891 New	891 $13,000
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $35,357 - $57,776	2,856 Added 142800.0%	2,858 $53,000
Q2 2022 Aug 15, 2022	SELL	$9.11 - $13.98 $136 - $209	-15 Reduced 88.24%	2 $0
Q1 2022 May 13, 2022	SELL	$6.87 - $11.11 $4,987 - $8,065	-726 Reduced 97.71%	17 $0
Q4 2021 Feb 11, 2022	BUY	$7.7 - $37.13 $5,721 - $27,587	743 New	743 $7,000
Q3 2021 Nov 12, 2021	SELL	$26.46 - $37.15 $0 - $0	0 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $0 - $0	0 New	0 $0

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.